Growth factors and oncogene products in transitional cell carcinoma

Modern Pathology

Volumn 9, Issue 3, 1996, Pages 292-297

  Nakanishi, Kuniaki ^a   Kawai, Toshiaki ^a   Suzuki, Minoru ^a   Torikata, Chikao ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

C erb B 2 oncoprotein; Epidermal growth factor; Epidermal growth factor receptor; Transforming growth factor ; Transitional cell carcinoma; Upper urinary tract

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; ONCOPROTEIN; TRANSFORMING GROWTH FACTOR;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PROGNOSIS; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 0029960155     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Huben RP, Mounzer AM, Murphy GP: Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 62:2016, 1988.
2. Batata M, Grabstald H: Upper urinary tract urothelial tumors. Urol Clin North Am 3:79, 1976.
3. Murphy DM, Zincke H, Furlow WL: Management of high-grade transitional cell cancer of the upper urinary tract. J Urol 125:25, 1981.
4. Akaza H, Koiso K, Niijima T: Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system. Cancer 59:1369, 1987.
5. Das AK, Carson CC, Bolick D, Paulson DF: Primary carcinoma of the upper urinary tract: Effect of primary and secondary therapy on survival. Cancer 66:1919, 1990.
6. Corrado F, Ferri C, Mannini D, et al.: Transitional cell carcinoma of the upper urinary tract: Evaluation of prognostic factors by histopathology and flow cytometric analysis. J Urol 145:1159, 1991.
7. Al-Abadi H, Nagel R: Transitional cell carcinoma of the renal pelvis and ureter. Prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: An 8-year survival time study. J Urol 148:31, 1992.
8. Smith K, Fennelly JA, Neal DE, Hall RR, Harris AL: Characterization and quantification of the epidermal growth factor receptor in invasive and superficial bladder tumors. Cancer Res 49:5810, 1989.
9. Berger MS, Greenfield C, Gullick WJ, et al.: Evaluation of epidermal growth factor receptors in bladder ytumors. Br J Cancer 56:533, 1987.
10. Neal DE, Marsh C, Bennett MK, et al.: Epidermal-growth-factor receptors in human bladder cancer: Comparison of invasive and superficial tumours. Lancet 1:366, 1985.
11. Limas C: Relationship of epidermal growth factor receptor detectability with the A, B, H blood group antigens: Emphasis on normal and neoplastic urothelium. Am J Pathol 139: 131, 1991.
12. Neal DE, Sharpies L, Smith K, et al.: The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619, 1990.
13. Wright C, Mellon K, Neal DE, et al.: Expression of c-erbB-2 protein product in bladder cancer. Br J Cancer 62:764, 1990.
14. Coombs LM, Pigott DA, Sweeney E, et al.: Amplification and over-expression of c-erb-B-2 in transitional cell carcinoma of the urinary bladder. Br J Cancer 63:601, 1991.
15. Sato K, Moriyama M, Mori S, et al.: An immunohistologic evaluation of c-erb-B-2 gene product in patients with urinary bladder carcinoma. Cancer 70:2493, 1992.
16. Wood DP, Wartinger DD, Reuter V, et al.: DNA RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder. J Urol 146:1398, 1991.
17. Coon JS, McCall A, Miller AW III, Farrow GM, Weinstein RS: Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder. Cancer 56:797, 1985.
18. Summers JL, Coon JS, Ward RM, Falor WH, Miller AW III, Weinstein RS: Prognosis in carcinoma of the urinary bladder based upon tissue blood group ABH and Thomsen-Friedenreich antigen status and karyotype of the initial tumor. Cancer Res 43:934, 1983.
19. Nakanishi K, Kawai T, Suzuki M: Lectin binding and expression of blood group-related antigens in carcinoma in situ and invasive carcinoma of urinary bladder. Histopathology 23:153, 1993.
20. Mukaida H, Toi M, Hirai T, Yamashita Y, Toge T: Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer. Cancer 68:142, 1991.
21. Liu C, Woo A, Tsao MS: Expression of transforming growth factor-α in primary human colon and lung carcinomas. Br J Cancer 62:425, 1990.
22. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR: Transforming growth factor-α and epidermal growth factor in human pancreatic cancer. J Pathol 163:111, 1991.
23. Lundy J, Schuss A, Stanick D, et al.: Expression of neu protein, epidermal growth factor receptor, and transforming growth factor-α in breast cancer: Correlation with clinicopathologic parameters. Am J Pathol 138:1527, 1991.
24. Tanaka S, Imanishi K, Yoshihara M, et al.: Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia. Am J Pathol 139:123, 1991.
25. Müller W, Borchard F: Expression of transforming growth factor-α in gastric carcinoma and normal gastric mucosa cells. Cancer 69:2871, 1992.
26. Baukneckt T, Angel P, Kohler M, et al.: Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-α, myc, jun, and metallothionein in human ovarian carcinomas: Classification of malignant phenotypes. Cancer 71:419, 1993.
27. Tsuda H, Hirohashi S, Shimosato Y, et al.: Correlation between histologic grade of malignancy and copy number of c-erb-B-2 gene in breast carcinoma: A retrospective analysis of 176 cases. Cancer 65:1794, 1990.
28. Yarden Y, Weinberg RA: Experimental approaches to hypothetical hormones: Detection of a candidate ligand of the neu protooncogene. Proc Natl Acad Sci U S A 86:3179, 1989.
29. Schechter AL, Hung MC, Vaidyanathan L, et al.: The neu gene: an erb-B-homologous gene distinct from and unlinked to the gene encoding the EGF-receptor. Science 229:976, 1985.
30. UICC (International Union Against Cancer): Renal pelvis and ureter. In Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours, Ed 3, p 270. Berlin, Springer-Verlag, 1992.
31. Koss LG: Tumors of the urinary bladder. In Atlas of Tumor Pathology, Second series, Fasc. 11, p 29. Washington, DC, Armed Forces Institute of Pathology, 1975.
32. SAS technical report P-217 SAS/STAT software: The PHREG procedure, Version 6, p 63. Cary NC, SAS Institute, 1991.
33. Slamon DJ, Godolphin W, Jones LA, et al.: Studies of the Her-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707, 1989.